1147 related articles for article (PubMed ID: 28941764)
1. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
[TBL] [Abstract][Full Text] [Related]
2. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
[TBL] [Abstract][Full Text] [Related]
3. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
[TBL] [Abstract][Full Text] [Related]
4. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.
Ketteler M; Elder GJ; Evenepoel P; Ix JH; Jamal SA; Lafage-Proust MH; Shroff R; Thadhani RI; Tonelli MA; Kasiske BL; Wheeler DC; Leonard MB
Kidney Int; 2015 Mar; 87(3):502-28. PubMed ID: 25651364
[TBL] [Abstract][Full Text] [Related]
5. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
Holden RM; Mustafa RA; Alexander RT; Battistella M; Bevilacqua MU; Knoll G; Mac-Way F; Reslerova M; Wald R; Acott PD; Feltmate P; Grill A; Jindal KK; Karsanji M; Kiberd BA; Mahdavi S; McCarron K; Molnar AO; Pinsk M; Rodd C; Soroka SD; Vinson AJ; Zimmerman D; Clase CM
Can J Kidney Health Dis; 2020; 7():2054358120944271. PubMed ID: 32821415
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.
Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
Ann Intern Med; 2018 Mar; 168(6):422-430. PubMed ID: 29459980
[TBL] [Abstract][Full Text] [Related]
7. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
[TBL] [Abstract][Full Text] [Related]
8. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
[TBL] [Abstract][Full Text] [Related]
9. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report.
Wang AY; Akizawa T; Bavanandan S; Hamano T; Liew A; Lu KC; Lumlertgul D; Oh KH; Zhao MH; Ka-Shun Fung S; Obi Y; Sumida K; Choong LHL; Goh BL; Hao CM; Kwon YJ; Tarng DC; Zuo L; Wheeler DC; Tsukamoto Y; Fukagawa M
Kidney Int Rep; 2019 Nov; 4(11):1523-1537. PubMed ID: 31890994
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
Chuang SH; Wong HC; Vathsala A; Lee E; How PP
Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726
[TBL] [Abstract][Full Text] [Related]
11. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
Kidney Int Suppl; 2009 Aug; (113):S1-130. PubMed ID: 19644521
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
[TBL] [Abstract][Full Text] [Related]
14. Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
Cozzolino M; Ureña-Torres P; Vervloet MG; Brandenburg V; Bover J; Goldsmith D; Larsson TE; Massy ZA; Mazzaferro S;
Nephrol Dial Transplant; 2014 Oct; 29(10):1815-20. PubMed ID: 24516228
[TBL] [Abstract][Full Text] [Related]
15. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM).
Torregrosa JV; Bover J; Rodríguez Portillo M; González Parra E; Dolores Arenas M; Caravaca F; González Casaus ML; Martín-Malo A; Navarro-González JF; Lorenzo V; Molina P; Rodríguez M; Cannata Andia J
Nefrologia (Engl Ed); 2023 Jun; 43 Suppl 1():1-36. PubMed ID: 37202281
[TBL] [Abstract][Full Text] [Related]
16. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
[TBL] [Abstract][Full Text] [Related]
17. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
18. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
[TBL] [Abstract][Full Text] [Related]
19. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
20. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
